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Abstract The AMP-activated protein kinase (AMPK) consists 
of catalytic a and non-catalytic, ß and y (38 kDa) subunits and is 
responsible for acting as a metabolic sensor for AMP levels. 
There are multiple genes for each subunit and we find that rat 
liver AMPK-OL2 isoform catalytic subunit is associated with ßl 
and yl and not with ß2 or y2 subunit isoforms. The ßl and yl 
isoforms are also subunits of the a l isoform. The sequence of 
cloned human AMPK-ßl is 95% identical in amino acid sequence 
with rat ß l . Human chromosomal localizations were determined 
for A M P K - a l (5p l l -p l4 ) , AMPK-ßl (12q24.1-24.3) and 
AMPK-yl (12ql2-ql4), respectively. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
The AMP-activated protein kinase (AMPK) consists of an 
a, catalytic subunit (63 kDa) and non-catalytic, ß (40 kDa) 
and y (38 kDa) subunits [1-3]. Co-expression of the non-cata-
lytic ß and y subunits is required for optimal activity of the a 
catalytic subunit [4]. The A M P K phosphorylates a number of 
key enzymes involved in the control of lipid metabolism : ace-
tyl-CoA carboxylase, H M G - C o A reductase and hormone-sen-
sitive lipase [5]. It is activated by elevation of intracellular 5'-
A M P caused by arsenite and heat shock and is thought to 
function primarily in stress responses [6]. Studies on H M G -
CoA reductase regulation have reinforced the concept that the 
A M P K plays a role in metabolic stress responses, since muta-
tion of Ser-871, the A M P K phosphorylation site in H M G -
CoA reductase, to Ala, blocked phosphorylation by the 
A M P K and reduction in H M G - C o A reductase activity caused 
by A T P depletion, but did not affect the transcriptional con-
trol of H M G - C o A reductase [7]. The activation of the A M P K 
by A M P results from three contributing mechanisms: direct 
allosteric activation of the enzyme, A M P activation of an 
upstream kinase [8] and A M P inhibition of A M P K dephos-
phorylation [9]. 
Recently, we found that multiple isoforms of the A M P K 
are present in liver [10]. Both a l and cc2 isoforms could be 
stimulated by 5 ' -AMP and contained non-catalytic ß and y 
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subunits. The two isoforms of the A M P K , a l and a 2 , are 
90% identical in the catalytic core region, but have divergent 
COOH-terminal tails (60% identical). In addition, EST se-
quence analysis of the ß and y non-catalytic subunits has 
revealed the presence of isoforms specific for each subunit 
within the human genome [11]. Since the A M P K consists of 
a family of isoenzymes, it was important to establish which ß 
and y subunit isoforms are bound to each catalytic isoform. 
Rat and porcine liver A M P K - a l subunits are associated with 
ßl and yl [3,12] but the identity of the non-catalytic subunits 
associated with A M P K - a 2 was uncertain and it seemed rea-
sonable that it may associate with a distinct set of ß and y 
non-catalytic subunits. In the present study, we have purified 
the rat liver A M P K - a 2 isoform and show by protein sequenc-
ing that it is associated with ßl and yl subunits. The chromo-
somal localization of the corresponding human genes has been 
determined. 
2. Materials and methods 
2.1. AMPK-cû purification 
Peptide antibodies were raised against AMPK-a2 (352-366) and 
(490-514) as previously described [10]. Affinity purified antibodies 
(400 ag each/ml beads) were coupled to 4 ml of Tosyl-activated Dy-
nabeads (DYNAL, Oslo, Norway) according to the manufacturer's 
instructions. Extracts of rat liver were processed as described previ-
ously for the purification of AMPK-a2 [13]. The fraction containing 
the AMPK-a2, which is not retained by the substrate affinity column 
[13] was incubated overnight at 4°C with the magnetic beads were 
then collected into one tube, washed with 5X1 ml of phosphate-buf-
fered saline and 5 X 1 ml of 50 mM Tris-HCl, pH 7.4, 1 mM EDTA, 
0.5 M NaCl and 1% Triton X-100 (w/v). The antigen was eluted with 
4X1 ml of 0.2 M glycine, pH 2.0, precipitated with trichloroacetic 
acid (6%) and analysed by SDS-PAGE. 
2.2. Protein sequencing 
Peptides were derived from rat ß and y subunits of AMPK sepa-
rated by SDS-PAGE using in-situ proteolysis described previously [1]. 
Briefly, Coomassie Blue-stained gel slices were excised and placed in 
the funnel compartment of a Hewlett Packard G1004B Chemstation 
where they were washed extensively in water, reduced in 5 funnel 
volumes ( ~ 5 ml) of 0.2 M Tris-HCl buffer containing 10 mM DTT 
and 1 mM EDTA, pH 8.5, at 45°C (3 h) and alkylated with 5 funnel 
volumes of 1% 4-vinylpyridine in 0.2 M Tris-HCl buffer, 1 mM 
EDTA, pH 8.5, at ambient temperature (2 h). The gel slices were 
destained in 7 funnel volumes of 50 mM ammonium bicarbonate, 
50% acetonitrile at 65°C for 3 h and dried in a centrifugal freeze drier. 
The gel slices were rehydrated in digestion buffer containing protease 
(30 (il/slice from a single lane of a 1 mm gel). Modified Trypsin 
(Promega) or achrombacter endoproteinase Lys-C (Wako) in either 
10% acetonitrile (v/v) 50 mM ammonium bicarbonate buffer for tryp-
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tic digests or adjusted to pH 9.2 with ammonia solution for Lys-C 
digests. The protease to substrate ratio was approximately 1:20 (w/w). 
The rehydrated gel slices were covered with an additional 200 ul of 
digestion buffer and incubated at 37°C overnight. Excess digestion 
buffer was removed and reserved. The gel slices were extracted with 
200 |xl of 2% (v/v) trifluoroacetic acid (TFA) and incubated in a 
sonicating water bath for 1 h. The supernatant was removed and 
pooled with the reserved digestion buffer. This procedure was re-
peated with 200 ul of 40% acetonitrile 0.1% TFA and finally 200 ul 
of 80% acetonitrile 0.1% TFA and the combined gel eluates were dried 
in a centrifugal freeze drier. The digest mixture was reconstituted in 
6 ul of 100% TFA, vortexed then 300 |xl of 6 M guanidine hydro-
chloride was added and the mixture was subject to chromatography 
on Nucleosil C18 5 |xm 300 A reversed-phase glass-lined column 
(SGE) (1 X250 mm) on a Pharmacia SMART system using a linear 
0-80% acetonitrile 0.1% TFA gradient over 120 min at 40 ul/min and 
the 214 nm peaks collected automatically. Peak purity was assessed 
using a Perspective Biosystems Voyager DE MALDI time-of-flight 
mass spectrometry with samples crystallised in the presence of a-cy-
ano-4-hydroxycinnamic acid and sequenced on a Hewlett Packard 
G1000A Protein Sequencer utilising Routine 3.5 Edman degradation 
chemistry as recommended by the manufacturer. 
2.3. Isolation of human AMPK cDNAs and genomic clones 
A genomic AMPK-al clone was obtained by screening a human PI 
genomic library (Genome Systems, Inc.) with a 387 bp region of 
AMPK-al cDNA (681-1065) and subcloned into two smaller frag-
ments. Following sequencing with AMPK-specific oligonucleotides, 
a 5000 bp subclone corresponding to the non-catalytic region of 
AMPK-al was chosen as the probe for chromosome localization. 
Human AMPK-ßl was identified as an EST (R20494) following 
BLAST algorithm [14] searches of the genome database with rat liver 
AMPK-ßl. R20494 was obtained from IMAGE clones and its cDNA 
sequence determined by dideoxy chain termination using vector and 
AMPK-ßl-specific oligonucleotides. Comparison of human AMPK-
ßl with rat AMPK-ßl [11] revealed 95% and 89% identity at the 
amino acid and nucleotide levels, respectively. Human AMPK-yl 
was isolated as previously described [11]. 
2.4. Chromosomal localization 
The following probes were employed: AMPK-ßl (1.75 kb cDNA in 
vector, R20494), AMPK-al ( ~ 5 kb genomic DNA in vector), and 
AMPK-yl (1.6 kb cDNA in vector, human fetal liver). The probes 
were nick-translated with biotin-14-dATP and hybridized individually 
in situ at a final concentration of 10-20 ng/ml to normal male meta-
phases. The fluorescence in situ hybridization (FISH) method was 
modified from that previously described [15] in that chromosomes 
were stained before analysis with both propidium iodide (as counter-
stain) and DAPI (for chromosome identification). Images of AMPK-
ßl preparations were captured by a cooled CCD camera using the 
Cyto Vision Ultra image collection and enhancement system (Applied 
Imaging Int. Ltd.). FISH signals and the DAPI banding pattern were 
merged for figure preparation. 
3. Results and discussion 
3.1. Subunit structure of the AMPK-cû isoform 
The AMPK-oc2 isoform was purified from rat liver by im-
munoaffinity chromatography using antibody against the 
AMPK-a2 catalytic subunit (Fig. 1). The identity of the 
AMPK-a2 catalytic subunit was verified by peptide sequence 
analysis with 17% of the subunit sequence obtained by in situ 
proteolysis. This included two peptides derived from the cata-
lytic core and three peptides from the COOH-terminal do-
main (Fig. 2A). The sequence comparisons confirm that it 
was the a2-isoform of the AMPK catalytic subunit which 
was immunoaffinity purified. The peptide sequences obtained 
for the corresponding ß subunit accounted for 46% of the 
expected 270 residues of protein sequence and were identical 
to the ßl sequence previously identified as the ß subunit iso-
form associated with the a l catalytic subunit (Fig. 2B). The 
Fig. 1. Subunit structure of rat liver AMPK-a2. AMPK-a2 was 
purified as described in Section 2. Shown is an SDS-PAGE (13%) 
containing the AMPK-a2 catalytic subunit together with the 
AMPK non-catalytic subunits, ß and y. The arrow indicates the 
presence of the antibody heavy chain. Molecular mass standards are 
shown in kDa. 
peptide sequence derived from the y subunit associated with 
the AMPK-oc2 isoform accounted for 43% of the sequence 
and this was identical to the yl isoform (Fig. 2C). These 
results demonstrate that the liver AMPK-oc2 catalytic subunit 
associates with the same set of non-catalytic subunits as the 
AMPK-al catalytic subunit and not with other isoforms of 
the non-catalytic subunits. Previously we found that both ßl 
and yl could associate with either a l or a2 when all three 
subunits were transfected into COS cells [4]. 
Recent genome sequencing has revealed multiple isoforms 
of both the ß and y subunits with two isoforms of the y sub-
unit revealed by EST sequences (Fig. 2C). Evidence for a y2 
isoform is based on partial-length cDNAs from human brain, 
accession numbers H15390 and H06773, and human liver, 
accession number H64260 (Fig. 2C) We raised anti-peptide 
antibodies to the putative y2 isoform (cDNA derived se-
quence, LTPAGAKQKETETE). Immunoprecipitation of the 
post Blue-Sepharose fractions [13] of the rat liver AMPK 
preparation with the anti-y2 antibody indicated that it was 
associated with a- and ß-like subunits but the quantity of 
material obtained was insufficient to allow amino acid se-
quence analysis. 
3.2. Chromosomal localization 
Twenty metaphases from a normal male were examined for 
fluorescent signal using the AMPK-al probe. Nineteen of 
these metaphases showed signal on one or both chromatids 
of chromosome 5 in the region 5pll-pl4; 85% of this signal 
was at 5pl2. There were a total of 39 non-specific background 
dots observed in these 19 metaphases. A similar result was 
obtained from hybridization of the probes to 15 metaphases 
from a second normal male (data not shown). To confirm that 
the signal was on chromosome 5 the Oncor probe D4Z1 was 
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Fig. 2. AMPK-oc2 isoform subunit sequences. AMPK-ct2 was purified and subjected to partial amino acid sequencing as described in Section 2. 
The sequences shown in panels A-C were aligned with the Pileup program (GCG, University of Wisconsin [18]) and formatted, with the resi-
dues identical to the AMPK isoenzyme-1 isoform being shaded. A: Alignment of the catalytic isoforms, AMPK-al (Alpha-1) and AMPK-a2 
(Alpha-2) and the peptide sequence derived from the purified AMPK-cc2 catalytic subunit shown in Fig. 1. B : Alignment of rat liver AMPK-
ßl [11], human brain AMPK-ßl (R20494), mouse AMPK-ß2 isoform (partial-length cDNA from mouse fetal lung, accession number W07176, 
as identified in the Genebank by BLAST searching) and the peptide sequence derived from the purified AMPK-ßl non-catalytic subunit shown 
in Fig. 1. C: Alignment of rat liver AMPK-yl [11], human AMPK-y2 isoform (partial-length cDNAs from human brain, accession numbers 
H15390 and H06773, and human liver, accession number H64260, as identified in the Genebank by BLAST searching) and the peptide se-
quence derived from the purified AMPK-yl non-catalytic subunit shown in Fig. 1. 
hybridized simultaneously. D4Z1 hybridizes to the centromere 
region of chromosome 4, so chromosome 4 could be separated 
from chromosome 5, hence allowing unequivocal identifica-
tion of the B group chromosomes. In contrast the AMPK-
cc2 gene mapped to lp31 (OMIM 600497) [16]. 
Twenty-five metaphases from a normal male were examined 
for fluorescent signal with the AMPK-ßl probe. Twenty-three 
of these metaphases showed signal on one or both chromatids 
of chromosome 12 in the region 12q24.1-q24.3; 90% of this 
signal was at 12q24.1 (Fig. 3). There was a total of seven non-
specific background dots observed in these 25 metaphases. A 
similar result was obtained from hybridization of the probe to 
21 metaphases from a second male (data not shown). The 
AMPK-$2 (Fig. 2B) gene has not yet had its chromosomal 
location determined. 
Twenty-five metaphases from a normal male were examined 
for fluorescent signal using the AMPK-yl probe. All of these 
metaphases showed signal on one or both chromatids of chro-
mosome 12 in the region 12ql2-ql4; 77% of this signal was at 
12ql3.1. There was a total of 20 non-specific background dots 
observed in these 25 metaphases. A similar result was ob-
tained from hybridization of the probes to 20 metaphases 
from the second normal male (data not shown). Twenty meta-
phases expressing the rare folate-sensitive site FRA12A, and 
showing signal, were then examined. Of these, 17 showed 
signal proximal to the fragile site, two showed signal central 
and one showed signal distal. We therefore infer that AMPK-
y is proximal to FRA12A. The precise location of FRA12A 
was described by Sutherland and Hecht as in the middle of 
band 12ql3.1 [17]. The AMPK-y2 gene (Fig. 2C) has recently 
been mapped to chromosome 7 by Genethon, marker 
A005S22 (D7S676-D7S505) corresponding to region 7q35-36. 
The results reported here show that the genes for the 
AMPK subunits (a, ß, y) and their isoforms are distributed 
over a number of chromosomes. In liver the AMPK-oe2 cata-
lytic subunit associates with ßl and yl non-catalytic subunits 
which also associate with AMPK-al. Thus the marked diver-
gence in the COOH-terminal sequences between the AMPK-
cc2 and AMPK-al catalytic subunits is not responsible for 
associating with different non-catalytic subunits. 
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